US 8389727
Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
granted A61KA61K31/4709A61K31/4748
Quick answer
US patent 8389727 (Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 53
- CPC classes
- A61K, A61K31/4709, A61K31/4748, A61P, A61P1/00